Physician profile
Phung Le
NPI 1932424066
$4,080.61
in general payments reported to CMS, 2019-2025
9 companies · $1,357 in 2025
The $1,357 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,021 · 2020: $109 · 2022: $78.97 · 2023: $1,454 · 2024: $60.40 · 2025: $1,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,049 · Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,049.03 |
| Food and Beverage | $821.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $1,325.83 | 2023 | Alif, Xlif |
| W. L. Gore & Associates, INC. | $1,281.36 | 2023-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Conformable Thoracic Endoprosthesis |
| Cook Incorporated | $880.70 | 2019 | |
| Endologix LLC | $253.65 | 2019-2023 | Alto Abdominal Stent Graft System |
| Medtronic, INC. | $124.05 | 2022-2025 | Endurant Iis, In.Pact Av |
| Cook Medical LLC | $85.46 | 2019-2022 | |
| Bolton Medical INC | $81.82 | 2023-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Bard Peripheral Vascular, INC. | $34.58 | 2025 | Rotarexs 6 F X 135 Cm |
| Boston Scientific Corporation | $13.16 | 2023 | Varithena Administration Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phung Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.